These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 29451)

  • 41. Adaptational phenomena in neuroleptic treatment.
    Nielsen IM; Christensen AV; Hyttel J
    Adv Biochem Psychopharmacol; 1978; 19():267-74. PubMed ID: 29449
    [No Abstract]   [Full Text] [Related]  

  • 42. The pharmacology of catecholamine involvement in the neural mechanisms of reward.
    Wauquier A
    Acta Neurobiol Exp (Wars); 1980; 40(3):665-86. PubMed ID: 6108051
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dopamine D-1 and D-2 receptors in relation to reward and performance: a case for the D-1 receptor as a primary site of therapeutic action of neuroleptic drugs.
    Miller R; Wickens JR; Beninger RJ
    Prog Neurobiol; 1990; 34(2):143-83. PubMed ID: 1969668
    [No Abstract]   [Full Text] [Related]  

  • 44. [Effects of dopaminergic stimulating agents, caffeine and antipsychotic drugs on rotational behaviour in mice with unilateral striatal 6-hydroxydopamine lesions (author's transl)].
    Watanabe H; Watanabe K; Hagino K; Ikeda M
    Yakugaku Zasshi; 1978 Dec; 98(12):1613-8. PubMed ID: 34706
    [No Abstract]   [Full Text] [Related]  

  • 45. A comparison of the vascular dopamine receptor with other dopamine receptors.
    Goldberg LI; Volkman PH; Kohli JD
    Annu Rev Pharmacol Toxicol; 1978; 18():57-79. PubMed ID: 348069
    [No Abstract]   [Full Text] [Related]  

  • 46. Action of classic and unusual neuroleptics on various behavioral apomorphine-induced effects.
    Boissier JR; Puech AJ; Simon P
    Adv Biochem Psychopharmacol; 1977; 16():631-4. PubMed ID: 18906
    [No Abstract]   [Full Text] [Related]  

  • 47. Dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs.
    Baldessarini RJ; Tarsy D
    Annu Rev Neurosci; 1980; 3():23-41. PubMed ID: 6106450
    [No Abstract]   [Full Text] [Related]  

  • 48. Conditioning of signs of a dopaminergic stimulation in rats.
    Kuschinksy K; Möller HG; Novak K; Walter S
    Pharmacopsychiatry; 1988 Nov; 21(6):317-8. PubMed ID: 2907637
    [No Abstract]   [Full Text] [Related]  

  • 49. The hypotheses of different dopamine receptor mechanisms.
    Costall B; Naylor RJ
    Life Sci; 1981 Jan; 28(3):215-29. PubMed ID: 6111725
    [No Abstract]   [Full Text] [Related]  

  • 50. Structure activity relationships of presynaptic dopamine receptor agonists.
    Bhatnagar RK; Arnerić SP; Cannon JG; Flynn J; Long JP
    Pharmacol Biochem Behav; 1982; 17 Suppl 1():11-9. PubMed ID: 7184032
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Climbing behavior permits in vivo assessment of pre- and postsynaptic extrapyramidal dopaminergic function in mice.
    Pinsky C; Brockhausen E; Dua AK; Bose R
    Neurosci Biobehav Rev; 1988; 12(3-4):195-8. PubMed ID: 3226643
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Supersensitivity to apomorphine and stress two years after chronic methadone treatment.
    Carlson KR
    Neuropharmacology; 1977 Nov; 16(11):795-8. PubMed ID: 413066
    [No Abstract]   [Full Text] [Related]  

  • 53. Dopamine, chick behavior, and states of attention.
    de Lanerolle NC; Millam JR
    J Comp Physiol Psychol; 1980 Apr; 94(2):346-52. PubMed ID: 7365005
    [No Abstract]   [Full Text] [Related]  

  • 54. New concepts in dopamine receptor plasticity.
    LaHoste GJ; Marshall JF
    Ann N Y Acad Sci; 1993 Nov; 702():183-96. PubMed ID: 7906498
    [No Abstract]   [Full Text] [Related]  

  • 55. Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence.
    Hornykiewicz O
    Neuroscience; 1978; 3(9):773-83. PubMed ID: 30919
    [No Abstract]   [Full Text] [Related]  

  • 56. Dopamine receptor alterations with aging in mouse and rat corpus striatum.
    Marquis JK; Lippa AS; Pelham RW
    Biochem Pharmacol; 1981 Jul; 30(13):1876-8. PubMed ID: 6268112
    [No Abstract]   [Full Text] [Related]  

  • 57. In vivo and in vitro intracellular recordings from rat midbrain dopamine neurons.
    Grace AA
    Ann N Y Acad Sci; 1988; 537():51-76. PubMed ID: 2849358
    [No Abstract]   [Full Text] [Related]  

  • 58. (-)N-(chloroethyl)norapomorphine inhibits striatal dopamine function via irreversible receptor binding.
    Costall B; Fortune DH; Law SJ; Naylor RJ; Neumeyer JL; Nohria V
    Nature; 1980 Jun; 285(5766):571-3. PubMed ID: 7402299
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Normal and abnormal determinants of dopamine receptor ontogeny in the central nervous system.
    Feigenbaum JJ; Yanai J
    Prog Neurobiol; 1984; 23(3):191-225. PubMed ID: 6240665
    [No Abstract]   [Full Text] [Related]  

  • 60. Pharmacological properties of dopamine receptors in rat submandibular gland cells.
    Murakami H; Sano M; Ishikawa T; Watanabe H; Sano A
    J Nihon Univ Sch Dent; 1984 Dec; 26(4):301-9. PubMed ID: 6597870
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.